Sanjay Garg

Prof Sanjay Garg

Professor of Pharmaceutical Science

School of Pharmacy and Biomedical Science

College of Health

Available For Media Comment.

PIDG: Your Partner in Translational Pharmaceutical Research

Recent Media Releases
3D Printing of Biodegradable anticancer drug film for liver cancer: UniSA and 7News
3D Printing of Oesophageal stents for anticancer drug delivery: UniSA and 7News
US FDA Approval and commercial launch of a Vaginal Contraceptive: UniSA and 7News
Improved Bioavailability of Curcumin: UniSA and 7News

Introduction
Professor Sanjay Garg is a pharmaceutical scientist dedicated to advancing drug discovery, development, and delivery to transform lives of human and animal patients. With a PhD in Pharmaceutical Sciences, Master's degree in Management, and a passion for innovation, he leads translational research that bridges cutting-edge science with practical healthcare solutions. As Co-Director of the Centre for Pharmaceutical Innovation (CPI) and Director of the Pharmaceutical Innovation and Development Group (PIDG) at the University of South Australia, Professor Garg drives pioneering research to develop novel therapeutics and delivery systems.
His patented formulations, including Acidform (USA Patent 6706276), have achieved significant global impact, with the FDA-approved non-hormonal contraceptive Phexxi marketed in the USA and other innovations reaching clinical stages and markets in India, New Zealand, the UK, and Australia. Previously, as Deputy Head of the Pharmacy School at the University of Auckland, he established a Good Laboratory Practice (GLP)-compliant analytical laboratory and played a pivotal role in developing research and postgraduate programs, nurturing the next generation of pharmaceutical scientists.
Professor Garg is committed to fostering interdisciplinary collaboration, working closely with researchers, industry leaders, and healthcare professionals to deliver patient-centric solutions. He actively seeks partnerships to advance pharmaceutical sciences and improve global health outcomes.
Research Focus
Prof. Garg's current research focuses on several critical areas of importance, including:

Anti-cancer Drug Targeting: Exploring 3D printing for precise drug delivery, both locally and systemically.
Infections: Widely collaborating on novel antimicrobial compounds and formulations for human and veterinary applications, leading to successful patents and infection-fighting products, especially for resistant infections (AMR).
Veterinary Delivery Systems: Over two decades of expertise in veterinary pharmaceuticals, developing cutting-edge drug delivery technologies, dosage protocols, and ensuring safety and efficacy for various animal species. The team has successfully developed several marketed and under animal trial veterinary formulations for horses, dogs, cats, fish, pigs, cattle, and other animals. Long-acting equine omeprazole injection is an example. 
Other Patient-centric Projects: Ongoing work benefiting patients, including compounding and drug analysis in human milk.

Research Outputs and Awards
Throughout his career, Professor Garg's contributions have been exceptional:

298 peer-reviewed papers
101 patents
24 book chapters
4 edited books
Technology transfer for 15 products

Sanjay is a highly cited researcher with an h-index of 72 (Google Scholar) and 59 (Scopus), and FWCI of 1.83. He has mentored 243 research scholars at all levels, including 9 current PhD students. His accolades include the Research and Enterprise Excellence Supervisor of the Year, the Australasian Pharmaceutical Science Association Medal, the Research Impact Awards finalist at UniSA, the President's Medal from the South Australian Indian Medical Association, the Butland Award for Excellence in Research Supervision, and the Fellowship of the Indian Pharmaceutical Association.
Collaborations
Professor Garg champions international engagement, serving as Co-Director of the China-Australia Centre for Health Science Research (Shandong University, China) and holding adjunct appointments with the International Medical University (IMU, Malaysia) and Manipal Academy of Higher Education (MAHE, India). He collaborates with pharmaceutical, biotechnological, nutrition, and complementary medicine companies, along with government agencies and foundations, across the USA, Canada, Brazil, India, Malaysia, and China. He continues to seek new opportunities for research collaboration and exchange.
He Chairs the expert group on substandard and falsified medicines for World Organization of Animal Health (WOAH).

  • Anticancer drug delivery and nanomedicine: Local and systemic tumor targeting, applications of nanoscience to drug development.
  • Infections, microbicides (MPT) and contraception: Novel antibacterial compounds and formulations for resistant pathogens (Superbugs) in human and veterinary applications; vaginal multipurpose prevention technologies (MPT) for contraception, HIV and STIs.
  • Translational drug development and delivery: Preformulation, physico-chemical characterization, solubility and stability assessment and improvement, patentable non-infringing platform technologies: nanotechnology, solid, semisolid and liquid dosage forms; reverse engineering, cosmetics and complementary medicines.
  • Novel veterinary delivery systems: for cattle, horses, cats, dogs, pigs and fish.
  • Pharmaceutical analysis, quality control and regulation: analysis of drugs, metabolites and excipients in the pure form, formulations; stability indicating analytical method development and validation; Good Laboratory Practices (GLP); quality assurance and control (QA and QC); regulatory documentation; registration dossier preparation and evaluation; Intellectual Property (IP) issues.
  • Paediatric Preparations: Extemporaneous compounding, shelf life assessment and improvement, formulation improvement.
  • Independent consulting in all of the above areas, pharmaceutical expert for patent and regulatory issues.

Year Citation
2026 Singh, B., Mahajan, S., Abdella, S., Khan, R., & Garg, S. (2026). Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management. Medicinal Research Reviews, 46(1), 272-298.
DOI
2026 Hoang, V. D., Nguyen, H. M. T., Nguyen, T. A., & Garg, S. (2026). Pharmaceutical Formulations and Analytical Methods of Donepezil. AAPS Pharmscitech, 27(1), 28.
DOI
2026 Uddin, A. M., Werid, G. M., Van, T. D., Song, Y., Garg, S., Kirkwood, R. N., & Petrovski, K. R. (2026). Injectable or non-injectable GnRH analogues for control of swine reproduction. A systematic review and meta-analysis. Theriogenology, 250, 117681-1-117681-9.
DOI
2025 Abid, F., Kim, S., Savaliya, B., Cesari, L., Amirmostofian, M., Abdella, S., . . . Garg, S. (2025). Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.. International journal of nanomedicine, 2025(20), 2181-2204.
DOI Scopus3 WoS3 Europe PMC1
2025 Koppisetti, H. P., Abdella, S., Nakmode, D. D., Abid, F., Afinjuomo, F., Kim, S., . . . Garg, S. (2025). Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care. Pharmaceutics, 17(5), 47 pages.
DOI Scopus1 WoS1 Europe PMC1
2025 Nakmode, D. D., Abdella, S., Song, Y., & Garg, S. (2025). Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson’s disease. Drug Delivery and Translational Research, 15(11), 4026-4042.
DOI
2025 Xu, X., Song, Y., Li, M., Liu, F., Zhang, H., Xu, J., . . . Garg, S. (2025). Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer. Materials Today Bio, 33(article no. 102012), 16 pages.
DOI
2025 Nakmode, D. D., Singh, B., Abdella, S., Song, Y., & Garg, S. (2025). Correction to: Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies (Drug Delivery and Translational Research, (2025), 15, 4, (1156-1180), 10.1007/s13346-024-01747-y). Drug Delivery and Translational Research, 15(4), 1454.
DOI
2025 Kassa, F. M., Youssef, S. H., Song, Y., & Garg, S. (2025). Use of Computational Intelligence in Customizing Drug Release from 3D-Printed Products: A Comprehensive Review. Pharmaceutics, 17(5), 26 pages.
DOI
2025 Khetan, R., Lokman, N. A., Eldi, P., Price, Z. K., Oehler, M. K., Brooks, D. A., . . . Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. International Journal of Molecular Sciences, 26(17), 8529.
DOI
2025 Uddin, A. H. M. M., Kirkwood, R. N., Petrovski, K. R., Youssef, S. H., Singh, B., Mukhopadhyay, S., . . . Garg, S. (2025). Evaluation of Permeation Enhancers for Vaginal Delivery of Buserelin Acetate Using a Validated Chromatographic Method and Ex Vivo Porcine Model. Pharmaceutics, 17(9), 1181.
DOI
2025 Uddin, A. H. M. M., Taechamaeteekul, P., Petrovski, K. R., Tummaruk, P., Song, Y., Garg, S., & Kirkwood, R. N. (2025). Development of Timed Release Vaginal Mucosal Cloprostenol for Farrowing Management in Sows. Pharmaceutics, 17(9), 1198.
DOI
2025 Dessai, A. D., Nair, A., Selvasudha, N., Garg, S., & Nayak, U. Y. (2025). Glyco-nanomaterials as a therapeutic target in drug delivery and biomedicine: a review. International Journal Of Biological Macromolecules, 329(147830), 1-42.
DOI Scopus1
2025 Arafat, M., Wignall, A., Brewer, K., Song, Y., Albrecht, H., Prestidge, C. A., . . . Blencowe, A. (2025). Comparison of polymer-coated, drug-eluting self-expandable metal stents for the potential treatment of gastrointestinal cancers. Rsc Pharmaceutics, 2(3), 611-623.
DOI
2025 Braun, A., Racz, J., Garg, S., & Bobrovskaya, L. (2025). Further characterisation of the intrastriatal 6-OHDA Parkinson's disease model with non-motor symptom replication and widespread catecholamine dysfunction in male mice. Neurochemistry International, 190(106054), 106054.
DOI
2025 Nakmode, D. D., Youssef, S. H., Das, S., Song, Y., & Garg, S. (2025). Analytical method for simultaneous quantification of levodopa and carbidopa in the injectable oleogel formulation by HPLC. BMC Chemistry, 19(1), 14 pages.
DOI Scopus2 WoS3 Europe PMC2
2025 Song, Y., Kim, S., Mukhopadhyay, S., Youssef, S. H., Tan, J. Q. E., Weir, E. J., . . . Garg, S. (2025). Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa. Pharmaceutics, 17(10), 19 pages.
DOI
2025 Mukhopadhyay, S., Youssef, S. H., Song, Y., Nayak, U. Y., & Garg, S. (2025). Harnessing the Power of Antimicrobial Peptides: From Mechanisms to Delivery Optimization for Topical Infections. Antibiotics, 14(4), 19 pages.
DOI Scopus2 WoS2 Europe PMC2
2025 Nakmode, D. D., Singh, B., Abdella, S., Song, Y., & Garg, S. (2025). Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies. Drug Delivery and Translational Research, 15(4), 1156-1180.
DOI Scopus4 WoS7 Europe PMC4
2025 Muta, T., Khetan, R., Song, Y., & Garg, S. (2025). Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation. International Journal of Molecular Sciences, 26(6), 28 pages.
DOI Scopus4 WoS4 Europe PMC3
2025 Youssef, S. H., & Garg, S. (2025). 3D printed biodegradable bilayer films: a promising frontier in liver cancer therapy. Expert Opinion on Drug Delivery, 1-7.
DOI
2025 Ashwini, T., Garg, S., Shenoy, P. A., Chandrashekhar, R., Nayak, Y., & Nayak, U. Y. (2025). A quality by design approach with comprehensive green analytical chemistry assessment: Development, validation, and application of a high-performance liquid chromatographic method for quantifying meropenem trihydrate in nanosponges and marketed formulations. Journal of Applied Pharmaceutical Science, 15(6), 70-95.
DOI Scopus1
2024 Rajapaksha, W., Khetan, R., Johnson, I. R. D., Blencowe, A., Garg, S., Albrecht, H., & Gillam, T. A. (2024). Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment. Frontiers in Drug Delivery, 4(1339936), 19 pages.
DOI Scopus10 WoS7 Europe PMC2
2024 Nair, A., Chandrashekhar H., R., Day, C. M., Garg, S., Nayak, Y., Shenoy, P. A., & Nayak, U. Y. (2024). Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insights. International Journal of Pharmaceutics, 660(124314), 37 pages.
DOI Scopus25 WoS26 Europe PMC12
2024 Singh, B., Day, C. M., Abdella, S., & Garg, S. (2024). Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management. Journal of Controlled Release, 367, 402-424.
DOI Scopus114 WoS93 Europe PMC79
2024 Mukhopadhyay, S., Narayan, R., Gadag, S., Shenoy, P. A., Garg, S., Ashwini, T., & Nayak, U. Y. (2024). Development of levofloxacin glycosylated mesoporous silica nanoparticles for urinary tract infections. Journal of Applied Pharmaceutical Science, 14(12), 174-179.
DOI Scopus4
2024 Abid, F., Virgo, E., Kennewell, T. L., Khetan, R., Haidari, H., Kopecki, Z., . . . Garg, S. (2024). The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in Wounds. Pharmaceutics, 16(11), 15 pages.
DOI Scopus1 WoS1
2024 Kim, S., Youssef, S. H., Lee, K. M. K., Song, Y., Vaidya, S., & Garg, S. (2024). Enhanced Skin Permeation of 5-Fluorouracil through Drug-in-Adhesive Topical Patches. Pharmaceutics, 16(3), 16 pages.
DOI Scopus2 WoS2 Europe PMC1
2024 Metcalf, L., Lomax, S., Van der Saag, D., Garg, S., & White, P. J. (2024). Pain Relief Interventions in Australian Livestock Husbandry: A Review of Animal Welfare and Pain Duration. Animals, 14(13), 18 pages.
DOI Scopus3 WoS3 Europe PMC2
2024 Abdella, S., Kim, S., Afinjuomo, F., Song, Y., Upton, R., & Garg, S. (2024). Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery. Drug Delivery and Translational Research, 14(4), 984-1004.
DOI Scopus17 WoS18 Europe PMC10
2024 Youssef, S. H., Ganesan, R., Amirmostofian, M., Kim, S., Polara, R., Afinjuomo, F., . . . Garg, S. (2024). Printing a Cure: A Tailored Solution for Localized Drug Delivery in Liver Cancer Treatment.. International journal of pharmaceutics, 651(123790), 123790.
DOI Scopus7 WoS6 Europe PMC6
2024 Youssef, S. H., Garg, A., Song, Y., Wylie, N. E., & Garg, S. (2024). Harmonising IV oxycodone with paediatric perioperative medications: a compatibility study through Y-type connectors. Drug Design, Development and Therapy, 18, 899-908.
DOI Scopus2 WoS1 Europe PMC2
2024 Khetan, R., Eldi, P., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Blencowe, A., . . . Albrecht, H. (2024). Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation.. J Ovarian Res, 17(1), 156.
DOI Scopus2 WoS2 Europe PMC2
2023 Uddin, A. H. M. M., Song, Y., Garg, S., Petrovski, K. R., & Kirkwood, R. N. (2023). Control of ovarian function using non-injection technologies for GnRH administration. Journal of Drug Delivery Science and Technology, 84(84, article no. 104502), 7 pages.
DOI Scopus2 WoS2
2023 Uddin, A. H. M. M., Petrovski, K. R., Song, Y., Garg, S., & Kirkwood, R. N. (2023). Application of Exogenous GnRH in Food Animal Production. Animals, 13(12), 1891-1-1891-14.
DOI Scopus12 WoS13 Europe PMC8
2023 Nguyen, H. T., Venter, H., Woolford, L., Young, K. A., McCluskey, A., Garg, S., . . . Trott, D. J. (2023). Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model. Antimicrobial Agents and Chemotherapy, 67(10), e0042423-1-e0042423-13.
DOI
2023 Song, Y., Abdella, S., Afinjuomo, F., Weir, E. J., Tan, J. Q. E., Hill, P., . . . Garg, S. (2023). Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products. BMC Veterinary Research, 19(1), 1-9.
DOI Scopus5 WoS3 Europe PMC3
2023 Abid, F., Savaliya, B., Parikh, A., Kim, S., Amirmostofian, M., Cesari, L., . . . Garg, S. (2023). Nanotechnology and narasin: a powerful combination against acne.. Nanoscale, 15(33), 13728-13739.
DOI Scopus8 WoS7 Europe PMC5
2023 Fernandes, N. B., Nayak, Y., Garg, S., & Nayak, U. Y. (2023). Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: theranostic perspectives. Coordination Chemistry Reviews, 478(article no. 214977), 1-28.
DOI Scopus67 WoS62
2023 Kim, S., Abdella, S., Abid, F., Afinjuomo, F., Youssef, S. H., Holmes, A., . . . Garg, S. (2023). Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach. International Journal of Nanomedicine, 18, 1007-1029.
DOI Scopus23 WoS18 Europe PMC14
2023 Kim, S., Day, C. M., Song, Y., Holmes, A., & Garg, S. (2023). Innovative Topical Patches for Non-Melanoma Skin Cancer: Current Challenges and Key Formulation Considerations. Pharmaceutics, 15(11), 26 pages.
DOI Scopus13 WoS11 Europe PMC10
2023 Nakmode, D. D., Day, C. M., Song, Y., & Garg, S. (2023). The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems. Pharmaceutics, 15(5), 28 pages.
DOI Scopus24 WoS20 Europe PMC20
2023 Sim, P., Song, Y., Abraham, S., & Garg, S. (2023). Harnessing the benefits of utilizing the optimal pH in conjunction with a hydrogel for wound care. Journal of Drug Delivery Science and Technology, 89(105027), 9 pages.
DOI Scopus7 WoS6
2023 Choudhury, H., Pandey, M., Saravanan, V., Mun, A. T. Y., Bhattamisra, S. K., Parikh, A., . . . Gorain, B. (2023). Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer. Biomaterials Advances, 153(213556), 28 pages.
DOI Scopus9 WoS8 Europe PMC6
2023 Youssef, S. H., Kim, S., Khetan, R., Afinjuomo, F., Song, Y., & Garg, S. (2023). The development of 5-fluorouracil biodegradable implants: A comparative study of PCL/PLGA blends. Journal of Drug Delivery Science and Technology, 81(104300), 14 pages.
DOI Scopus14 WoS13
2023 Song, Y., Day, C. M., Afinjuomo, F., Tan, J. Q. E., Page, S. W., & Garg, S. (2023). Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?. Pharmaceutics, 15(1), 25 pages.
DOI Scopus18 WoS17 Europe PMC12
2023 Abdella, S., Abid, F., Youssef, S. H., Kim, S., Afinjuomo, F., Malinga, C., . . . Garg, S. (2023). pH and its applications in targeted drug delivery. Drug Discovery Today, 28(1), 103414.
DOI Scopus69 Europe PMC37
2022 Youssef, S. H., Abdella, S., & Garg, S. (2022). Development and Validation of a Novel Tool for Assessing the Environmental Impact of 3D Printing Technologies: A Pharmaceutical Perspective. Pharmaceutics, 14(5), 19 pages.
DOI Scopus10 WoS8 Europe PMC5
2022 Gadag, S., Narayan, R., Sabhahit, J. N., Hari, G., Nayak, Y., Pai, K. S. R., . . . Nayak, U. Y. (2022). Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer. Biomaterials Advances, 140(213085), 1-18.
DOI Scopus24 WoS19 Europe PMC9
2022 Garg, S. (2022). Foreword. Computer Aided Pharmaceutics and Drug Delivery an Application Guide for Students and Researchers of Pharmaceutical Sciences, vii-viii.
2022 Shrivastava, N., Parikh, A., Dewangan, R. P., Biswas, L., Verma, A. K., Mittal, S., . . . Baboota, S. (2022). Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer. Pharmaceutics, 14(7), 34 pages.
DOI Scopus38 WoS32 Europe PMC16
2022 Bazeed, A. Y., Day, C. M., & Garg, S. (2022). Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies. Cancers, 14(17), 36 pages.
DOI Scopus48 WoS42 Europe PMC39
2022 Kim, S., Fouladian, P., Afinjuomo, F., Song, Y., Youssef, S. H., Vaidya, S., & Garg, S. (2022). Effect of plasticizers on drug-in-adhesive patches containing 5-fluorouracil. International Journal of Pharmaceutics, 611(121316), 12 pages.
DOI Scopus17 WoS13 Europe PMC8
2022 Kim, S., Youssef, S. H., Song, Y., & Garg, S. (2022). Development and application of a chromatographic method for simultaneous quantification of 5-fluorouracil and imiquimod in drug-in-adhesive topical patches. Sustainable Chemistry and Pharmacy, 27, 11 pages.
DOI Scopus5 WoS5
2022 Gadag, S., Narayan, R., Nayak, Y., Garg, S., & Nayak, U. Y. (2022). Design, development and evaluation of Resveratrol transdermal patches for breast cancer therapy. International Journal of Pharmaceutics, 632(article no. 122558), 1-14.
DOI Scopus12 WoS12 Europe PMC6
2022 Narayan, R., Gadag, S., Garg, S., & Nayak, U. Y. (2022). Understanding the effect of functionalization on loading capacity and release of drug from mesoporous silica nanoparticles: a computationally driven study. ACS Omega, 7(10), 8229-8245.
DOI Scopus25 WoS24 Europe PMC17
2022 Abdella, S., Afinjuomo, F., Song, Y., Upton, R., & Garg, S. (2022). 3D printed bilayer mucoadhesive buccal film of estradiol: Impact of design on film properties, release kinetics and predicted in vivo performance. International Journal of Pharmaceutics, 628(122324), 15 pages.
DOI Scopus18 WoS18 Europe PMC13
2022 Abdella, S., Afinjuomo, F., Song, Y., Upton, R., & Garg, S. (2022). Mucoadhesive Buccal Film of Estradiol for Hormonal Replacement Therapy: Development and In-Vivo Performance Prediction. Pharmaceutics, 14(3), 24 pages.
DOI Scopus24 WoS20 Europe PMC14
2022 Nguyen, H. T., Venter, H., Woolford, L., Young, K., McCluskey, A., Garg, S., . . . Ogunniyi, A. D. (2022). Impact of a novel anticoccidial analogue on systemic staphylococcus aureus infection in a bioluminescent mouse model. Antibiotics, 11(1), 1-16.
DOI Scopus2 WoS2 Europe PMC2
2022 Abid, F., Youssef, S. H., Song, Y., Parikh, A., Trott, D., Page, S. W., & Garg, S. (2022). Development and validation of a new analytical method for estimation of narasin using refractive index detector and its greenness evaluation. Microchemical Journal, 175(article no. 107149), 1-7.
DOI Scopus10 WoS10
2022 Ward, S. A., Kirkwood, R. N., Plush, K. J., Abdella, S., Song, Y., & Garg, S. (2022). Development of a Novel Vaginal Drug Delivery System to Control Time of Farrowing and Allow Supervision of Piglet Delivery. Pharmaceutics, 14(2), 17 pages.
DOI Scopus7 WoS7 Europe PMC2
2022 Ward, S. A., Kirkwood, R. N., Song, Y., Garg, S., & Plush, K. J. (2022). Effect of Dexamethasone and Route of Administration on Sow Farrowing Behaviours, Piglet Delivery and Litter Performance. Animals, 12(7), 1-10.
DOI Scopus7 WoS6 Europe PMC5
2022 Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler-Hoffmann, M., Ricciardelli, C., . . . Albrecht, H. (2022). Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers, 14(10), 1-32.
DOI Scopus12 WoS12 Europe PMC11
2022 Deng, I., Garg, S., Zhou, X. F., & a Bobrovskaya, L. (2022). The effects of novel formulations of edaravone and curcumin in the mouse intrastriatal lipopolysaccharide model of Parkinson's disease. Frontiers in bioscience (Scholar edition), 14(2), 1-17.
DOI Scopus4 Europe PMC3
2022 Sim, P., Song, Y., Yang, G. N., Cowin, A. J., & Garg, S. (2022). In vitro wound healing properties of novel acidic treatment regimen in enhancing metabolic activity and migration of skin cells. International Journal of Molecular Sciences, 23(13, article no. 7188), 1-15.
DOI Scopus18 WoS17 Europe PMC10
2022 Sim, P., Strudwick, X. L., Song, Y., Cowin, A. J., & Garg, S. (2022). Influence of acidic pH on wound healing in vivo: a novel perspective for wound treatment. International Journal Of Molecular Sciences, 23(21), 1-15.
DOI Scopus162 WoS148 Europe PMC89
2021 Haidari, H., Kopecki, Z., Sutton, A. T., Garg, S., Cowin, A. J., & Vasilev, K. (2021). pH-responsive "smart" hydrogel for controlled delivery of silver nanoparticles to infected wounds. Antibiotics, 10(1), 49-1-49-15.
DOI Scopus118 WoS112 Europe PMC60
2021 Li, R., Song, Y., Fouladian, P., Arafat, M., Chung, R., Kohlhagen, J., & Garg, S. (2021). Three-dimensional printing of curcumin-loaded biodegradable and flexible scaffold for intracranial therapy of glioblastoma multiforme. Pharmaceutics, 13(4, article no. 471), 1-9.
DOI Scopus35 WoS32 Europe PMC22
2021 Haidari, H., Bright, R., Strudwick, X. L., Garg, S., Vasilev, K., Cowin, A. J., & Kopecki, Z. (2021). Multifunctional ultrasmall AgNP hydrogel accelerates healing of S. aureus infected wounds. Acta Biomaterialia, 128, 420-434.
DOI Scopus111 WoS104 Europe PMC69
2021 Nguyen, H. T., Morshed, M. T., Vuong, D., Crombie, A., Lacey, E., Garg, S., . . . Ogunniyi, A. D. (2021). Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections. Antibiotics, 10(6), 727-1-727-17.
DOI Scopus1
2021 Deng, I., Corrigan, F., Garg, S., Zhou, X. F., & Bobrovskaya, L. (2021). Further characterization of intrastriatal lipopolysaccharide model of parkinson’s disease in c57bl/6 mice. International Journal of Molecular Sciences, 22(14), 20 pages.
DOI Scopus13 WoS11 Europe PMC10
2021 Li, R., Ting, Y. H., Youssef, S. H., Song, Y., & Garg, S. (2021). Three-dimensional printing for cancer applications: research landscape and technologies. Pharmaceuticals, 14(8, article no. 787), 1-24.
DOI Scopus33 WoS25 Europe PMC16
2021 Haidari, H., Bright, R., Garg, S., Vasilev, K., Cowin, A. J., & Kopecki, Z. (2021). Eradication of mature bacterial biofilms with concurrent improvement in chronic wound healing using silver nanoparticle hydrogel treatment. Biomedicines, 9(9), 1182-1-1182-20.
DOI Scopus51 WoS50 Europe PMC32
2021 Haidari, H., Bright, R., Kopecki, Z., Zilm, P. S., Garg, S., Cowin, A. J., . . . Goswami, N. (2021). Polycationic silver nanoclusters comprising nanoreservoirs of Ag+ ions with high antimicrobial and antibiofilm activity. ACS Applied Materials and Interfaces, 14(1), 390-403.
DOI Scopus73 WoS71 Europe PMC41
2021 Abdella, S., Youssef, S. H., Afinjuomo, F., Song, Y., Fouladian, P., Upton, R., & Garg, S. (2021). 3d printing of thermo‐sensitive drugs. Pharmaceutics, 13(9), 27 pages.
DOI Scopus59 WoS50 Europe PMC37
2021 Day, C. M., Sweetman, M. J., Hickey, S. M., Song, Y., Liu, Y., Zhang, N., . . . Garg, S. (2021). Concept design, development and preliminary physical and chemical characterization of tamoxifen-guided-mesoporous silica nanoparticles. Molecules, 26(1, article no. 219), 1-15.
DOI Scopus11 WoS10 Europe PMC5
2021 Gadag, S., Narayan, R., Nayak, A. S., Catalina Ardila, D., Sant, S., Nayak, Y., . . . Nayak, U. Y. (2021). Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy. International Journal of Pharmaceutics, 606(120877), 1-17.
DOI Scopus67 WoS58 Europe PMC36
2021 Arafat, M., Fouladian, P., Wignall, A., Song, Y., Parikh, A., Albrecht, H., . . . Blencowe, A. (2021). Development and in vitro evaluation of 5-fluorouracil-eluting stents for the treatment of colorectal cancer and cancer-related obstruction. Pharmaceutics, 13(1), 1-22.
DOI Scopus23 WoS20 Europe PMC11
2021 Zhang, M., Qin, X., Xu, W., Wang, Y., Song, Y., Garg, S., & Luan, Y. (2021). Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy. Journal of Colloid and Interface Science, 594, 493-501.
DOI Scopus144 WoS137 Europe PMC83
2021 Fouladian, P., Jin, Q., Arafat, M., Song, Y., Guo, X., Blencowe, A., & Garg, S. (2021). Drug-loaded, polyurethane coated nitinol stents for the controlled release of docetaxel for the treatment of oesophageal cancer. Pharmaceuticals, 14(4), 16 pages.
DOI Scopus12 WoS10 Europe PMC6
2021 Youssef, S. H., Afinjuomo, F., Song, Y., & Garg, S. (2021). Development of a novel chromatographic method for concurrent determination of 5-fluorouracil and cisplatin: Validation, greenness evaluation, and application on drug-eluting film. Microchemical Journal, 168(106510), 9 pages.
DOI Scopus21 WoS20
2021 Narayan, R., Gadag, S., Cheruku, S. P., Raichur, A. M., Day, C. M., Garg, S., . . . Nayak, U. Y. (2021). Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Carbohydrate Polymers, 261(117893), 15 pages.
DOI Scopus78 WoS68 Europe PMC35
2021 Arafat, M., Song, Y., Brewer, K., Fouladian, P., Parikh, A., Albrecht, H., . . . Garg, S. (2021). Pharmaceutical development of 5-fluorouracil- eluting stents for the potential treatment of gastrointestinal cancers and related obstructions. Drug Design Development and Therapy, 15, 1495-1507.
DOI Scopus8 WoS9 Europe PMC5
2021 Afinjuomo, F., Abdella, S., Youssef, S. H., Song, Y., & Garg, S. (2021). Inulin and its application in drug delivery. Pharmaceuticals, 14(9), 37 pages.
DOI Scopus92 WoS73 Europe PMC46
2021 Narayan, R., Gadag, S., Mudakavi, R. J., Garg, S., Raichur, A. M., Nayak, Y., . . . Nayak, U. Y. (2021). Mesoporous silica nanoparticles capped with chitosan-glucuronic acid conjugate for pH-responsive targeted delivery of 5-fluorouracil. Journal of Drug Delivery Science and Technology, 63(102472), 1-12.
DOI Scopus27 WoS20
2021 Day, C. M., Sweetman, M. J., Song, Y., Plush, S. E., & Garg, S. (2021). Functionalized mesoporous silica nanoparticles as delivery systems for doxorubicin: Drug loading and release. Applied Sciences Switzerland, 11(13), 10 pages.
DOI Scopus24 WoS21
2020 Gadag, S., Sinha, S., Nayak, Y., Garg, S., & Nayak, U. Y. (2020). Combination therapy and nanoparticulate systems: Smart approaches for the effective treatment of breast cancer. Pharmaceutics, 12(6), 1-37.
DOI Scopus38 WoS30 Europe PMC22
2020 Costabile, M., Day, C., Garg, S., & Aldous, G. (2020). Development, implementation and evaluation of an innovative, project-based assignment for final year pharmacy students, relating to novel drug delivery systems. Pharmacy Education, 20(1), 67-75.
2020 Pansara, C., Mishra, R., Mehta, T., Parikh, A., & Garg, S. (2020). Formulation of chitosan stabilized silver nanoparticle-containing wound healing film: in-vitro and in-vivo characterization. Journal of Pharmaceutical Sciences, 109(7), 2196-2205.
DOI Scopus56 WoS53 Europe PMC25
2020 Fouladian, P., Kohlhagen, J., Arafat, M., Afinjuomo, F., Workman, N., Abuhelwa, A. Y., . . . Blencowe, A. (2020). Three-dimensional printed 5-fluorouracil eluting polyurethane stents for the treatment of oesophageal cancers. Biomaterials Science, 8(23), 6625-6636.
DOI Scopus36 WoS21 Europe PMC18
2020 Vitali, D., Bagri, P., Wessels, J. M., Arora, M., Ganugula, R., Parikh, A., . . . Kaushic, C. (2020). Curcumin can decrease tissue inflammation and the severity of HSV-2 infection in the female reproductive mucosa. International Journal of Molecular Sciences, 21(1), 19 pages.
DOI Scopus49 WoS41 Europe PMC31
2020 Fouladian, P., Afinjuomo, F., Arafat, M., Bergamin, A., Song, Y., Blencowe, A., & Garg, S. (2020). Influence of polymer composition on the controlled release of docetaxel: A comparison of non-degradable polymer films for oesophageal drug-eluting stents. Pharmaceutics, 12(5), 17 pages.
DOI Scopus12 WoS11 Europe PMC6
2020 Saleem, S., Iqubal, M. K., Garg, S., Ali, J., & Baboota, S. (2020). Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis. Expert Opinion on Drug Delivery, 17(6), 817-838.
DOI Scopus64 WoS61 Europe PMC38
2020 Song, Y., Lwin, E. M. P., Ellis, D., Turner, S., Williams, D., & Garg, S. (2020). Stability evaluation of an extemporaneously compounded carbimazole oral suspension. Journal of Pharmacy Practice and Research, 50(4), 329-334.
DOI Scopus1
2020 Muta, T., Parikh, A., Kathawala, K., Haidari, H., Song, Y., Thomas, J., & Garg, S. (2020). Quality-by-design approach for the development of nano-sized tea tree oil formulation-impregnated biocompatible gel with antimicrobial properties. Pharmaceutics, 12(11), 1-16.
DOI Scopus23 WoS22 Europe PMC11
2020 Afinjuomo, F., Fouladian, P., Barclay, T. G., Song, Y., Petrovsky, N., & Garg, S. (2020). Influence of oxidation degree on the physicochemical properties of oxidized inulin. Polymers, 12(5), 18 pages.
DOI Scopus24 WoS24 Europe PMC12
2020 Day, C. M., Hickey, S. M., Song, Y., Plush, S. E., & Garg, S. (2020). Novel tamoxifen nanoformulations for improving breast cancer treatment: Old wine in new bottles. Molecules, 25(5), 27 pages.
DOI Scopus68 WoS55 Europe PMC39
2020 Haidari, H., Garg, S., Vasilev, K., Kopecki, Z., & Cowin, A. J. (2020). Silver-based wound dressings: Current issues and future developments for treating bacterial infections. Wound Practice and Research, 28(4), 173-180.
DOI Scopus34 WoS33
2020 Leggett, C., Lwin, E. M. P., Ritchie, U., Song, Y., Gerber, J. P., Turner, S., . . . Garg, S. (2020). Perindopril in Breast Milk and Determination of Breastfed Infant Exposure: A Prospective Observational Study. Drug Design, Development and Therapy, 14, 961-967.
DOI Scopus6 WoS5 Europe PMC5
2020 Pi, H., Nguyen, H. T., Venter, H., Boileau, A. R., Woolford, L., Garg, S., . . . Ogunniyi, A. D. (2020). In vitro activity of robenidine Analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice. Front Microbiol, 11(1556), 1556.
DOI Scopus18 WoS17 Europe PMC16
2020 Haidari, H., Kopecki, Z., Bright, R., Cowin, A. J., Garg, S., Goswami, N., & Vasilev, K. (2020). Ultrasmall AgNP-impregnated biocompatible hydrogel with highly effective biofilm elimination properties. ACS Applied Materials and Interfaces, 12(37), 41011-41025.
DOI Scopus118 WoS117 Europe PMC73
2019 Khazandi, M., Pi, H., Chan, W. Y., Ogunniyi, A. D., Sim, J. X. F., Venter, H., . . . Trott, D. J. (2019). In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogens. Frontiers in Microbiology, 10(837), 837-1-837-15.
DOI Scopus24 WoS22 Europe PMC19
2019 Afinjuomo, F., Barclay, T. G., Parikh, A., Song, Y., Chung, R., Wang, L., . . . Garg, S. (2019). Design and characterization of inulin conjugate for improved intracellular and targeted delivery of pyrazinoic acid to monocytes. Pharmaceutics, 11(5), 243-1-243-22.
DOI Scopus13 WoS9 Europe PMC9
2019 Haidari, H., Goswami, N., Bright, R., Kopecki, Z., Cowin, A. J., Garg, S., & Vasilev, K. (2019). The interplay between size and valence state on the antibacterial activity of sub-10 nm silver nanoparticles. Nanoscale Advances, 1(6), 2365-2371.
DOI Scopus34 WoS34 Europe PMC18
2019 Afinjuomo, F., Barclay, T. G., Parikh, A., Chung, R., Song, Y., Nagalingam, G., . . . Garg, S. (2019). Synthesis and characterization of pH-sensitive inulin conjugate of isoniazid for monocyte-targeted delivery. Pharmaceutics, 11(11), 555-1-555-19.
DOI Scopus21 WoS20 Europe PMC10
2019 Wang, L., Song, Y., Parikh, A., Joyce, P., Chung, R., Liu, L., . . . Garg, S. (2019). Doxorubicin-loaded delta inulin conjugates for controlled and targeted drug delivery: development, characterization, and in vitro evaluation. Pharmaceutics, 11(11), 581-1-581-17.
DOI Scopus30 WoS25 Europe PMC19
2019 Pansara, C., Chan, W. Y., Parikh, A., Trott, D. J., Mehta, T., Mishra, R., & Garg, S. (2019). Formulation optimization of chitosan-stabilized silver nanoparticles using in vitro antimicrobial assay. Journal of Pharmaceutical Sciences, 108(2), 1007-1016.
DOI Scopus29 WoS26 Europe PMC8
2019 Mehta, C. H., Narayan, R., Aithal, G., Pandiyan, S., Bhat, P., Dengale, S., . . . Garg, S. (2019). Molecular simulation driven experiment for formulation of fixed dose combination of Darunavir and Ritonavir as anti-HIV nanosuspension. Journal of molecular liquids, 293(111469), 1-16.
DOI Scopus33 WoS30
2019 Garg, S., Aldous, G., Day, C., & Costabile, M. (2019). DEVELOPMENT, IMPLEMENTATION AND EVALUATION OF AN INNOVATIVE, PROJECT-BASED ASSIGNMENT FOR PHARMACY AND PHARMACEUTICAL SCIENCE STUDENTS, RELATING TO ADVANCED DRUG DELIVERY SYSTEMS. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 15(5), E22.
DOI WoS1
2019 Afinjuomo, F., Barclay, T. G., Song, Y., Parikh, A., Petrovsky, N., & Garg, S. (2019). Synthesis and characterization of a novel inulin hydrogel crosslinked with pyromellitic dianhydride. Reactive and Functional Polymers, 134, 104-111.
DOI Scopus62 WoS51
2019 Barclay, T. G., Day, C. M., Petrovsky, N., & Garg, S. (2019). Review of polysaccharide particle-based functional drug delivery. Carbohydrate Polymers, 221, 94-112.
DOI Scopus351 WoS296 Europe PMC177
2019 Afinjuomo, F., Fouladian, P., Parikh, A., Barclay, T. G., Song, Y., & Garg, S. (2019). Preparation and characterization of oxidized inulin hydrogel for controlled drug delivery. Pharmaceutics, 11(7), 21 pages.
DOI Scopus57 WoS47 Europe PMC30
2019 Bergamin, A., Mantzioris, E., Cross, G., Deo, P., Garg, S., & Hill, A. M. (2019). Nutraceuticals: reviewing their role in chronic disease prevention. Pharmaceutical medicine, 33(4), 291-309.
DOI Scopus43 WoS26 Europe PMC17
2019 Arafat, M., Fouladian, P., Blencowe, A., Albrecht, H., Song, Y., & Garg, S. (2019). Drug-eluting non-vascular stents for localised drug targeting in obstructive gastrointestinal cancers. Journal of Controlled Release, 308, 209-231.
DOI Scopus31 WoS27 Europe PMC17
2018 Sarwal, A., Singh, G., Singh, K., & Garg, S. (2018). Recent interventions for nanotechnology based drug products: Insights into the regulatory aspects. Current Pharmaceutical Design, 24(43), 5219-5228.
DOI Scopus15 WoS9 Europe PMC8
2018 Zhang, Q., Song, Y., Page, S. W., & Garg, S. (2018). Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel. Journal of Pharmaceutical Sciences, 107(2), 587-594.
DOI Scopus12 WoS11 Europe PMC10
2018 Aithal, G. C., Nayak, U. Y., Mehta, C., Narayan, R., Gopalkrishna, P., Pandiyan, S., & Garg, S. (2018). Localized in situ nanoemulgel drug delivery system of quercetin for periodontitis: development and computational simulations. Molecules, 23(6), 1-15.
DOI Scopus59 WoS49 Europe PMC37
2018 Song, Y., Whey Chin, Z., Ellis, D., Phyo Lwin, E. M., Turner, S., Williams, D., & Garg, S. (2018). Stability of an extemporaneously compounded minoxidil oral suspension. American Journal of Health System Pharmacy, 75(5), 309-315.
DOI Scopus7 WoS6 Europe PMC1
2018 Jiang, W., Zhang, H., Wu, J., Zhai, G., Li, Z., Luan, Y., & Garg, S. (2018). CuS@MOF-Based Well-Designed Quercetin Delivery System for Chemo-Photothermal Therapy. ACS Applied Materials and Interfaces, 10(40), 34513-34523.
DOI Scopus165 WoS160 Europe PMC85
2018 Kosari, S., Walker, E. J., Anderson, C., Peterson, G. M., Naunton, M., Castillo Martinez, E., . . . Thomas, J. (2018). Power outages and refrigerated medicines: The need for better guidelines, awareness and planning. Journal of Clinical Pharmacy and Therapeutics, 43(5), 737-739.
DOI Scopus7 WoS6 Europe PMC6
2018 Singh, A., & Amiji, M. M. (Eds.) (2018). Stimuli-responsive Drug Delivery Systems.
DOI
2018 Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S. (2018). Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics, 10(3, article no. 118), 1-49.
DOI Scopus786 WoS700 Europe PMC375
2018 Lwin, E. M. P., Leggett, C., Ritchie, U., Gerber, C., Song, Y., Hague, W., . . . Garg, S. (2018). Transfer of rosuvastatin into breast milk: Liquid chromatography-mass spectrometry methodology and clinical recommendations. Drug Design, Development and Therapy, 12, 3645-3651.
DOI Scopus20 WoS18 Europe PMC15
2018 Jiang, D., Mu, W., Pang, X., Liu, Y., Zhang, N., Song, Y., & Garg, S. (2018). Cascade cytosol delivery of dual-sensitive micelle-tailored vaccine for enhancing cancer immunotherapy. ACS applied materials and interfaces, 10(44), 37797-37811.
DOI Scopus40 WoS37 Europe PMC23
2018 Garcia, J., Garg, A., Song, Y., Fotios, A., Andersen, C., & Garg, S. (2018). Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion. PLoS one, 13(1, article no. e0190577), 1-13.
DOI Scopus17 WoS14 Europe PMC9
2018 Zhang, W., Song, Y., Eldi, P., Guo, X., Hayball, J., Garg, S., & Albrecht, H. (2018). Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles. International Journal of Nanomedicine, 13, 293-305.
DOI Scopus47 WoS36 Europe PMC24
2018 Mahendran, V. J., Stringer, A. M., Semple, S. J., Song, Y., & Garg, S. (2018). Advances in the use of anti-inflammatory agents to manage chemotherapy-induced oral and gastrointestinal mucositis. Current pharmaceutical design, 24(14), 1518-1532.
DOI Scopus25 WoS20 Europe PMC19
2018 Lwin, E., Gerber, C., Leggett, C., Song, Y., Ritchie, U., Turner, S., . . . Garg, S. (2018). Estimation of Atenolol Transfer Into Milk and Infant Exposure During Its Use in Lactating Women. Journal of Human Lactation, 34(3), 592-599.
DOI Scopus9 WoS10 Europe PMC10
2018 Ogunniyi, A., Kopecki, Z., Hickey, E., Khazandi, M., Peel, E., Belov, K., . . . Trott, D. (2018). Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing. PLoS ONE, 13(7), e0200195-1-e0200195-13.
DOI Scopus27 WoS27 Europe PMC20
2018 Hickey, E., Wong, H., Khazandi, M., Ogunniyi, A., Petrovski, K., Garg, S., . . . Trott, D. (2018). Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens. Journal of Veterinary Pharmacology and Therapeutics, 41(5), 746-754.
DOI Scopus19 WoS18 Europe PMC15
2018 Parikh, A., Kathawala, K., Song, Y., Zhou, X. F., & Garg, S. (2018). Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability. Drug Delivery and Translational Research, 8(5), 1389-1405.
DOI Scopus39 WoS31 Europe PMC22
2018 Parikh, A., Kathawala, K., Li, J., Chen, C., Shan, Z., Cao, X., . . . Garg, S. (2018). Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease. Drug delivery and translational research, 8(5), 1406-1420.
DOI Scopus39 WoS34 Europe PMC31
2018 Parikh, A., Kathawala, K., Li, J., Chen, C., Shan, Z., Cao, X., . . . Zhou, X. F. (2018). Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model. Drug Design, Development and Therapy, 12, 2111-2128.
DOI Scopus24 WoS22 Europe PMC16
2018 Parikh, A., Kathawala, K., Tan, C. C., Garg, S., & Zhou, X. F. (2018). Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement. Drug Design, Development and Therapy, 12, 2051-2069.
DOI Scopus30 WoS26 Europe PMC20
2017 Parikh, A., Kathawala, K., Tan, C. C., Garg, S., & Zhou, X. F. (2017). Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation. Drug delivery, 24(1), 962-978.
DOI Scopus32 WoS30 Europe PMC24
2017 Lwin, E. M. P., Gerber, C., Song, Y., Leggett, C., Ritchie, U., Turner, S., & Garg, S. (2017). A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk. Analytical and bioanalytical chemistry, 409(26), 6141-6148.
DOI Scopus11 WoS11 Europe PMC5
2017 Ogunniyi, A., Khazandi, M., Stevens, A., Sims, S., Page, S., Garg, S., . . . Trott, D. (2017). Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent. PLoS ONE, 12(9), e0183457-1-e0183457-23.
DOI Scopus38 WoS36 Europe PMC34
2017 Garg, S., Wang, W., Song, Y., Eats, P., Trott, D., Page, S., & Petrovski, K. (2017). Development of Intramammary Drug Delivery Systems: Novel In Vitro Release Method. Journal of Pharmaceutical Sciences, 106(3), 866-871.
DOI Scopus4 WoS4 Europe PMC4
2017 Ma, N., Liu, J., He, W., Li, Z., Luan, Y., Song, Y., & Garg, S. (2017). Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. Journal of colloid and interface science, 490, 598-607.
DOI Scopus139 WoS124 Europe PMC73
2017 Shaikh, M., Zhang, H., Wang, H., Guo, X., Song, Y., Kanwar, J. R., & Garg, S. (2017). In vitro and in vivo assessment of docetaxel formulation developed for esophageal stents. AAPS PharmSciTech, 18(1), 130-137.
DOI Scopus11 WoS11 Europe PMC7
2017 Lwin, E. M. P., Gerber, C., Song, Y., Leggett, C., Ritchie, U., Turner, S., & Garg, S. (2017). A new LC-MS/MS bioanalytical method for atenolol in human plasma and milk. Bioanalysis, 9(7), 517-530.
DOI Scopus15 WoS14 Europe PMC7
2017 Haidari, H., Zhang, Q., Melville, E., Kopecki, Z., Song, Y., Cowin, A., & Garg, S. (2017). Development of topical delivery systems for flightless neutralizing antibody. Journal of Pharmaceutical Sciences, 106(7), 1795-1804.
DOI Scopus14 WoS16 Europe PMC10
2017 Zhang, B., Song, Y., Wang, T., Yang, S., Zhang, J., Liu, Y., . . . Garg, S. (2017). Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer. International Journal of Nanomedicine, 12, 2871-2886.
DOI Scopus20 WoS19 Europe PMC8
2017 Knight, E., Trott, D., Page, S., Garg, S., Zhang, Q., Song, Y., . . . Shipstone, M. (2017). In vitro comparison of the dermal penetration of three different topical formulations containing lasalocid. Veterinary Dermatology, 28(4), 342-347.
DOI Scopus2 WoS2
2017 Sykes, B. W., Kathawala, K., Song, Y., Garg, S., Page, S. W., Underwood, C., & Mills, P. C. (2017). Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse. Equine Veterinary Journal, 49(6), 795-801.
DOI Scopus40 WoS35 Europe PMC22
2017 Wang, L., Barclay, T., Song, Y., Joyce, P., Sakala, I. G., Petrovsky, N., & Garg, S. (2017). Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant. Vaccine, 35(34), 4382-4388.
DOI Scopus18 WoS18 Europe PMC14
2016 Uppalapati, D., Boyd, B. J., Garg, S., Travas Sejdic, J., & Svirskis, D. (2016). Conducting polymers with defined micro- or nanostructures for drug delivery. Biomaterials, 111, 149-162.
DOI Scopus100 WoS86 Europe PMC43
2016 Narayan, R., Singh, M., Ranjan, O., Nayak, Y., Garg, S., Shavi, G. V., & Nayak, U. Y. (2016). Development of risperidone liposomes for brain targeting through intranasal route. Life sciences, 163, 38-45.
DOI Scopus114 WoS93 Europe PMC66
2016 Lwin, E. M. P., Ellis, D., Song, Y., Turner, S., & Garg, S. (2016). Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension. Annals of Pharmacotherapy, 50(2), 155-156.
DOI
2016 Song, Y., Peressin, K., Wong, P. Y., Page, S. W., & Garg, S. (2016). Key Considerations in Designing Oral Drug Delivery Systems for Dogs. Journal of Pharmaceutical Sciences, 105(5), 1576-1585.
DOI Scopus12 WoS10 Europe PMC7
2016 Zhang, W., Garg, S., Eldi, P., Zhou, F., Johnson, I., Brooks, D., . . . Albrecht, H. (2016). Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide. International Journal of Pharmaceutics, 513(1-2), 270-279.
DOI Scopus27 WoS25 Europe PMC17
2016 Shaikh, M., Roy Choudhury, N., Knott, R., Kanwar, J., & Garg, S. (2016). Effect of polymer microstructure on the docetaxel release and stability of polyurethane formulation. European Journal of Pharmaceutics and Biopharmaceutics, 101, 82-89.
DOI Scopus8 WoS7 Europe PMC2
2016 Li, N., Huang, C., Luan, Y., Song, A., Song, Y., & Garg, S. (2016). Active targeting co-delivery system based on pH-sensitive methoxy-poly(ethylene glycol)2K-poly(ε-caprolactone)4K-poly(glutamic acid)1K for enhanced cancer therapy. Journal of Colloid and Interface Science, 472, 90-98.
DOI Scopus28 WoS26 Europe PMC17
2016 Zhang, B., Wang, T., Yang, S., Xiao, Y., Song, Y., Zhang, N., & Garg, S. (2016). Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy. Journal of controlled release, 238, 10-21.
DOI Scopus87 WoS85 Europe PMC59
2016 Parikh, A., Kathawala, K., Tan, C. C., Garg, S., & Zhou, X. F. (2016). Development of a novel oral delivery system of edaravone for enhancing bioavailability. International Journal of Pharmaceutics, 515(1-2), 490-500.
DOI Scopus41 WoS38 Europe PMC28
2015 Lim, S. M., Pang, Z. W., Tan, H. Y., Shaikh, M., Adinarayana, G., & Garg, S. (2015). Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. Drug development and industrial pharmacy, 41(11), 1847-1855.
DOI Scopus37 WoS31 Europe PMC21
2015 Wang, W., Song, Y., Petrovski, K., Eats, P., Trott, D., Wong, H., . . . Garg, S. (2015). Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: Impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle. Drug Design, Development and Therapy, 9, 631-642.
DOI Scopus24 WoS22 Europe PMC12
2015 Khazandi, M., Eats, P., Trott, D., Ebrahimie, E., Perry, J., Hickey, E., . . . Petrovski, K. (2015). Development of an improved Streptococcus uberis experimental mastitis challenge model using different doses and strains in lactating dairy cows. Journal of Dairy Research, 82(4), 470-477.
DOI Scopus8 WoS8 Europe PMC7
2015 Shaikh, M., Choudhury, N. R., Knott, R., & Garg, S. (2015). Engineering Stent Based Delivery System for Esophageal Cancer Using Docetaxel. Molecular Pharmaceutics, 12(7), 2305-2317.
DOI Scopus27 WoS26 Europe PMC18
2015 Garg, A., Chan, D., Ambados, F., Lwin, E., Song, Y., & Garg, S. (2015). Penicillin stability in prefilled syringes for the purpose of skin testing for drug allergy. Journal of Allergy and Clinical Immunology in Practice, 3(4), 599-601.
DOI Scopus3 WoS3 Europe PMC2
2015 Simpson, B. S., Luo, X., Wang, J., Song, Y., Claudie, D. J., Garg, S., . . . Semple, S. J. (2015). Development and evaluation of a topical anti-inflammatory preparation containing Dodonaea polyandra extract. Journal of Pharmacy and Pharmaceutical Sciences, 18(4), 578-599.
DOI Scopus8 WoS7 Europe PMC4
2015 Pariyadan, M. V., Hotham, E. D., Turner, S., & Garg, S. (2015). Ethics and compliance hurdles in conducting multicentre low-risk research. Medical Journal of Australia, 203(8), 324-3e1.
DOI Scopus3 WoS3 Europe PMC2
2015 Kanwar, J. R., Roy, K., Patel, Y., Zhou, S. F., Singh, M. R., Singh, D., . . . Kanwar, R. K. (2015). Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions. Molecules, 20(6), 9703-9731.
DOI Scopus122 WoS100 Europe PMC69
2015 Tótoli, E. G., Garg, S., & Nunes, S. H. R. (2015). Daptomycin: Physicochemical, analytical, and pharmacological properties. Therapeutic Drug Monitoring, 37(6), 699-710.
DOI Scopus23 WoS22 Europe PMC15
2015 Li, N., Zhang, P., Huang, C., Song, Y., Garg, S., & Luan, Y. (2015). Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance. Rsc Advances, 5(95), 77986-77995.
DOI Scopus39 WoS35
2014 Wahlster, P., Scahill, S., Garg, S., & Babar, Z. U. D. (2014). Identifying stakeholder opinion regarding access to 'high-cost medicines' : a systematic review of the literature. Central European Journal of Medicine, 9(3), 513-527.
DOI Scopus7 WoS6
2014 Mohsin, S., Arellano, I. H., Choudhury, N. R., & Garg, S. (2014). Docetaxel epimerization in silicone films: a case of drug excipient incompatibility. Drug Testing and Analysis, 6(10), 1076-1084.
DOI Scopus6 WoS5 Europe PMC5
2013 Chen, S., Cao, Y., Ferguson, L. R., Shu, Q., & Garg, S. (2013). Evaluation of mucoadhesive coatings of chitosan and thiolated chitosan for the colonic delivery of microencapsulated probiotic bacteria. Journal of microencapsulation, 30(2), 103-115.
DOI Scopus77 WoS60 Europe PMC31
2013 Jin, Y., Wen, J., Garg, S., Liu, D. A., Zhou, Y., Teng, L., & Zhang, W. (2013). Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. International journal of nanomedicine, 8, 421-430.
DOI Scopus107 WoS81 Europe PMC49
2013 Ye, J., Zhang, W. Y., Meng, Q. F., Li, D. H., Garg, S., Teng, L. R., & Wen, J. Y. (2013). Forced degradation of flavonol glycosides extracted from Ginkgo biloba. Chemical research in Chinese universities, 29(4), 667-670.
DOI Scopus10 WoS10
2013 Shaikh, M., Kichenadasse, G., Choudhury, N., Butler, R., & Garg, S. (2013). Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience. Journal of Controlled Release, 172(1), 105-117.
DOI Scopus46 WoS39 Europe PMC23
2013 Grey, A., Garg, S., Dray, M., Purvis, L., Horne, A., Callon, K., . . . Cundy, T. (2013). Low-dose fluoride in postmenopausal women: A randomized controlled trial. Journal of clinical endocrinology and metabolism, 98(6), 2301-2307.
DOI Scopus23 WoS20 Europe PMC14
2013 Awasthi, A., Razzak, M., Al Kassas, R., Harvey, J., & Garg, S. (2013). Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method. Acta pharmaceutica, 63(1), 59-69.
DOI Scopus5 WoS3 Europe PMC3
2013 Talekar, M., Ganta, S., Amiji, M., Jamieson, S., Kendall, J., Denny, W. A., & Garg, S. (2013). Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy. International journal of pharmaceutics, 450(1), 278-289.
DOI Scopus37 WoS32 Europe PMC22
2013 Sharma, M., Waterhouse, G. I. N., Loader, S. W. C., Garg, S., & Svirskis, D. (2013). High surface area polypyrrole scaffolds for tunable drug delivery. International journal of pharmaceutics, 443(1), 163-168.
DOI Scopus105 WoS100 Europe PMC40
2013 Gargiulo, D. A., Chemal, C., Joda, L., Lee, Y. J., Pilkington, M., Haywood, A., & Garg, S. (2013). Extemporaneous compounding in veterinary practice: a New Zealand perspective. New Zealand veterinary journal, 61(6), 311-315.
DOI Scopus9 WoS8 Europe PMC7
2013 Garg, S., Sabri, D., Kanji, J., Rakkar, P. S., Lee, Y., Naidoo, N., & Svirskis, D. (2013). Evaluation of vitamin D medicines and dietary supplements and the physicochemical analysis of selected formulations. Journal of Nutrition Health and Aging, 17(2), 158-161.
DOI Scopus20 WoS22 Europe PMC21
2013 Babar, Z. U. D., Pengelly, K., Scahill, S. L., Garg, S., & Shaw, J. (2013). Migrant health in New Zealand: exploring issues concerning medicines access and use. Journal of pharmaceutical health services research, 4(1), 41-49.
DOI Scopus25 WoS20
2013 Gorajana, A., Ying, C. C., Shuang, Y., Fong, P., Tan, Z., Gupta, J., . . . Garg, S. (2013). Development of solid dispersion systems of dapivirine to enhance its solubility. Current drug delivery, 10(3), 309-316.
DOI Scopus9 WoS10 Europe PMC7
2013 Lockhart, M. M., Babar, Z. U. D., Carswell, C., & Garg, S. (2013). New Zealand's Drug Development Industry. International journal of environmental research and public health, 10(9), 4339-4351.
DOI Scopus6 WoS7 Europe PMC3
2013 Babar, Z. U. D., Scahill, S. L., Akhlaq, M., & Garg, S. (2013). A bibliometric review of pharmacy education literature in the context of low- to middle-income countries. Currents in pharmacy teaching and learning, 5(3), 218-232.
DOI Scopus37 WoS29
2013 Svirskis, D., Sharma, M., Yu, Y., & Garg, S. (2013). Electrically switchable polypyrrole film for the tunable release of progesterone. Therapeutic delivery, 4(3), 307-313.
DOI Scopus28 WoS28 Europe PMC15
2013 Koh, P. T., Chuah, J. N., Talekar, M., Gorajana, A., & Garg, S. (2013). Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. Indian journal of pharmaceutical sciences, 75(3), 291-301.
DOI Scopus47 WoS43 Europe PMC25
2013 Awasthi, A., Razzak, M., Al Kassas, R., Harvey, J., & Garg, S. (2013). Analytical Profile of Moxidectin. Profiles of drug substances, excipients and related methodology, 38, 315-366.
DOI Scopus17 Europe PMC14
2013 Garg, S., Hasan, R., Scahill, S., & Ud-Din Babar, Z. (2013). Investigating inspection practices of pharmaceutical manufacturing facilities in selected Arab countries: Views of inspectors and pharmaceutical industry employees. Eastern Mediterranean Health Journal, 19(11), 919-929.
DOI Scopus3 WoS2 Europe PMC1
2013 Garg, S., Hasan, R., Scahill, S., & Babar, Z. U. D. (2013). Investigating inspection practices of pharmaceutical manufacturing facilities in selected Arab countries: Views of inspectors and pharmaceutical industry employees | Enquete sur les pratiques d'inspection des etablissements de production pharmaceutique dans des pays arabes selectionnes: Opinions des inspecteurs et des employes de l'industrie pharmaceutique. Eastern mediterranean health journal, 19(11), 919-929.
2012 Rajinikanth, P. S., Keat, N. W., & Garg, S. (2012). Self-nanoemulsifying drug delivery systems of Valsartan : preparation and in-vitro characterization. International journal of drug delivery, 4(2), 153-163.
DOI Scopus15
2012 Lockhart, M. M., Babar, Z. U. D., & Garg, S. (2012). Drug development and research in New Zealand: policies affecting the industry. Drug development research, 73(1), 1-10.
DOI Scopus2 WoS2
2012 Awasthi, A., Razzak, M., Al Kassas, R., Harvey, J., & Garg, S. (2012). An overview on chemical derivatization and stability aspects of selected avermectin derivatives. Chemical and Pharmaceutical Bulletin, 60(8), 931-944.
DOI Scopus36 WoS33 Europe PMC20
2012 Talekar, M., Kendall, J., Denny, W., Jamieson, S., & Garg, S. (2012). Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol- 3-kinase inhibitor. European journal of pharmaceutical sciences, 47(5), 824-833.
DOI Scopus24 WoS25 Europe PMC16
2012 Awasthi, A., Razzak, M., Al Kassas, R., Greenwood, D. R., Harvey, J., & Garg, S. (2012). Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR. Journal of pharmaceutical and biomedical analysis, 63, 62-73.
DOI Scopus19 WoS19 Europe PMC11
2012 Chen, S., Zhao, Q., Ferguson, L. R., Shu, Q., Weir, I., & Garg, S. (2012). Development of a novel probiotic delivery system based on microencapsulation with protectants. Applied microbiology and biotechnology, 93(4), 1447-1457.
DOI Scopus40 WoS37 Europe PMC19
2012 Lockhart, M. M., Babar, Z. U. D., & Garg, S. (2012). Drug development in NZ: can a country be a cluster?. Drug development research, 73(1), 51-58.
DOI
2012 Awasthi, A., Razzak, M., Al Kassas, R., Greenwood, D., Harvey, J., & Garg, S. (2012). Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR. Analytical and bioanalytical chemistry, 404(8), 2203-2222.
DOI Scopus18 WoS18 Europe PMC14
2012 Chen, S., Cao, Y., Ferguson, L. R., Shu, Q., & Garg, S. (2012). Flow cytometric assessment of the protectants for enhanced in vitro survival of probiotic lactic acid bacteria through simulated human gastro-intestinal stresses. Applied microbiology and biotechnology, 95(2), 345-356.
DOI Scopus31 WoS28 Europe PMC18
2012 Awasthi, A., Razzak, M., Al Kassas, R., Greenwood, D. R., Harvey, J., & Garg, S. (2012). Separation and identification of degradation products in abamectin formulation using LC, LTQ FT-MS, H/D exchange and NMR. Current pharmaceutical analysis, 8(4), 415-430.
DOI Scopus5 WoS4
2012 Chen, S., Cao, Y., Ferguson, L., Shu, Q., & Garg, S. (2012). The effect of immobilization of probiotic Lactobacillus reuteri DPC16 in sub-100 um microcaspsule on food-borne pathogens. World journal of microbiology and biotechnology, 28(6), 2447-2452.
DOI Scopus12 WoS9 Europe PMC5
2012 Garg, S., Kauffmann, K., Othman, A., Ticehurst, R., Sharma, M., & Svirskis, D. (2012). Stability assessment of extemporaneous formulation of amoxicillin for parenteral antimicrobial therapy. Current Pharmaceutical Analysis, 8(4), 375-380.
DOI Scopus4 WoS4
2012 Talekar, M., Ganta, S., Singh, A., Amiji, M., Kendall, J., Denny, W. A., & Garg, S. (2012). Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells. Pharmaceutical Research, 29(10), 2874-2886.
DOI Scopus38 WoS27 Europe PMC18
2011 Svirskis, D., Wright, B. E., Travas-Sejdic, J., & Garg, S. (2011). Intrinsically Conducting Polymer Platforms for Electrochemically Controlled Drug Delivery. Active implants and scaffolds for tissue regeneration, 8, 481-512.
DOI Scopus3
2011 Talekar, M., Kendall, J., Denny, W., & Garg, S. (2011). Targeting of nanoparticles in cancer : drug delivery and diagnostics. Anti-Cancer Drugs, 22(10), 949-962.
DOI Scopus102 WoS97 Europe PMC70
2011 Chen, S., Ferguson, L. R., Shu, Q., & Garg, S. (2011). The application of flow cytometry to the characterisation of a probiotic strain Lactobacillus reuteri DPC16 and the evaluation of sugar preservatives for its lyophilization. LWT- food science and technology, 44(9), 1873-1879.
DOI Scopus13 WoS13
2011 Garg, A., Garg, S., & She, R. (2011). Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation. Burns, 37(7), 1150-1153.
DOI Scopus11 WoS7 Europe PMC6
2011 Cazedey, E., Othman, A., Garg, S., & Salgado, H. (2011). A Validated Stability-Indicating LC Method for Orbifloxacin in the Presence of Degradation Products. Current pharmaceutical analysis, 7(3), 176-181.
DOI Scopus6 WoS6
2011 Lyn, L., Sze, H., Rajendran, A., Adinarayana, G., Dua, K. K., & Garg, S. (2011). Crystal modifications and dissolution rate of piroxicam. Acta pharmaceutica, 61(4), 391-402.
DOI Scopus32 WoS28 Europe PMC12
2011 Lockhart, M. M., Babar, Z. U. D., & Garg, S. (2011). Clinical trials in New Zealand: progress, people, and policies. Drug development research, 72(4), 299-304.
DOI Scopus3 WoS1
2011 Svirskis, D., Travas-Sejdic, J., & Garg, S. (2011). A stability indicating HPLC method for the determination of electrochemically controlled release of risperidone. Journal of Chromatographic Science, 49(10), 780-785.
DOI Scopus11 WoS11
2011 Sharma, P., Zujovic, Z. D., Bowmaker, G. A., Marshall, A. J., Denny, W. A., & Garg, S. (2011). Erratum: Evaluation of a crystalline nanosuspension: Polymorphism, process induced transformation and in vivo studies (International Journal of Pharmaceutics (2011) 408 (138-151)). International Journal of Pharmaceutics, 413(1-2), 283.
DOI
2011 Sharma, P., & Garg, S. (2011). Corrigendum to "Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs" [Advanced Drug Delivery Reviews 62 (2010) 491-502]. Advanced Drug Delivery Reviews, 63(14-15), 1372.
DOI
2011 Sharma, P., Zujovic, Z. D., Bowmaker, G., Denny, W. A., & Garg, S. (2011). Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. International journal of pharmaceutics, 408(1/2), 138-151.
DOI Scopus52 WoS51 Europe PMC35
2011 Gupta, J., Othman, A., Tao, J. Q., & Garg, S. (2011). Development and validation of a HPLC method for simultaneous determination of Dapivirine and DS003 in combination Microbicide tablet. Current pharmaceutical analysis, 7(1), 21-26.
DOI Scopus7 WoS6
2010 Svirskis, D., Wright, B., Travas Sejdic, J., Rodgers, A., & Garg, S. (2010). Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system. Sensors and actuators B : chemical, 151(1), 97-102.
DOI Scopus39 WoS40
2010 Lockhart, M., Babar, Z. U. D., & Garg, S. (2010). Evaluation of policies to support drug development in New Zealand. Health policy, 96(2), 108-117.
DOI Scopus12 WoS10 Europe PMC6
2010 Lockhart, M. M., Babar, Z. U. D., & Garg, S. (2010). New Zealand's drug development industry - strengths and opportunities. New Zealand Medical Journal, 123(1314), 52-58.
2010 Lockhart, M. M., Babar, Z. U. D., & Garg, S. (2010). New Zealand's drug development industry - Strengths and opportunities. New Zealand Medical Journal, 123(1317).
Scopus5 WoS4 Europe PMC2
2010 Svirskis, D., Wright, B., Travas Sejdic, J., Rodgers, A., & Garg, S. (2010). Development of a controlled release system for risperidone using polypyrrole: mechanistic studies. Electroanalysis, 22(4), 439-444.
DOI Scopus48 WoS47
2010 Garg, S., Goldman, D., Krumme, M., Rohan, L. C., Smoot, S., & Friend, D. (2010). Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral research, 88(s1), s19-s29.
DOI Scopus105 WoS97 Europe PMC59
2010 Svirskis, D., Travas Sejdic, J., Rodgers, A., & Garg, S. (2010). Electrochemically controlled drug delivery based on intrinsically conducting polymers. Journal of controlled release, 146(1), 6-15.
DOI Scopus408 WoS373 Europe PMC174
2010 Sharma, P., & Garg, S. (2010). Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Advanced Drug Delivery Reviews, 62(4-5), 491-502.
DOI Scopus156 WoS140 Europe PMC95
2010 Ganta, S., Sharma, P., Paxton, J. W., Baguley, B. C., & Garg, S. (2010). Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. Journal of drug targeting, 18(2), 125-133.
DOI Scopus51 WoS39 Europe PMC24
2009 Sharma, P., Ganta, S., Denny, W., & Garg, S. (2009). Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative : chlorambucil. International journal of pharmaceutics, 367(1/2), 187-194.
DOI Scopus55 WoS48 Europe PMC25
2009 Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2009). Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. International journal of pharmaceutics, 367(1/2), 179-186.
DOI Scopus119 WoS107 Europe PMC79
2009 Garg, S., Svirskis, D., Al Kabban, M., Farhan, S., Komeshi, M., Lee, J., . . . Kairuz, T. (2009). Chemical stability of extemporaneously compounded omeprazole formulations: a comparison of two methods of compounding. International journal of pharmaceutical compounding, 13(3), 250-253.
Scopus9
2009 Sharma, P., Denny, W. A., & Garg, S. (2009). Effect of wet milling process on the solid state of indomethacin and simvastatin. International journal of pharmaceutics, 380(1/2), 40-48.
DOI Scopus130 WoS112 Europe PMC66
2009 Salgado, H. R. N., Moreno, A., & Garg, S. (2009). LC-DAD determination of fleroxacin in bulk and pharmaceutical dosage forms. Chromatographia, 69(s2), s237-s240.
DOI Scopus9 WoS7
2008 Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008). Development and validation of bioanalytical method for the determination of asulacrine in plasma by liquid chromatography. Journal of pharmaceutical and biomedical analysis, 46(2), 386-390.
DOI Scopus5 WoS5 Europe PMC4
2008 Romano, J., Malcolm, R., Garg, S., Rohan, L., & Kaptur, P. E. (2008). Microbicide delivery: formulation technologies and strategies. Current Opinion in HIV and AIDS, 3(5), 558-566.
DOI Scopus34 WoS31 Europe PMC31
2008 Ganta, S., Devalapally, H., Baguley, B. C., Garg, S., & Amiji, M. (2008). Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. Journal of Biomedical Nanotechnology, 4(2), 165-173.
Scopus33
2008 Garg, S., Svirskis, D., Myftiu, J., Behayaa, M., Shahin, D., Thrimawithana, T., . . . Kairuz, T. (2008). Properties of a formulated paediatric phenobarbitone oral liquid. Journal of Pharmacy Practice and Research, 38(1), 28-31.
DOI
2008 Butcher, J. C., Garg, S., Kim, D. Y., & Sharma, P. (2008). A modified approach to predict dissolution and absorption of polydisperse powders. Pharmaceutical Research, 25(10), 2309-2311.
DOI Scopus7 WoS7 Europe PMC6
2008 Bansal, D., & Garg, S. (2008). Probiotics : from functional foods to pharmaceutical products. Current pharmaceutical biotechnology, 9(4), 267-287.
DOI Scopus28 WoS23 Europe PMC5
2008 Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008). Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. International journal of pharmaceutics, 360(1/2), 115-121.
DOI Scopus71 WoS61 Europe PMC39
2008 Ganta, S., Devalapally, H., Baguley, B. C., Garg, S., & Amiji, M. (2008). Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. Journal of biomedical nanotechnology, 4(2), 165-173.
DOI Europe PMC30
2007 Garg, S., & Kumar, G. (2007). Development and evaluation of a buccal bioadhesive system for smoking cessation therapy. Pharmazie, 62(4), 266-272.
DOI Scopus21 WoS17 Europe PMC10
2007 Kairuz, T., Chhim, S., Hasan, F., Kumar, K., Lal, A., Patel, R., . . . Garg, S. (2007). Extemporaneous compounding in a sample of New Zealand hospitals: A retrospective survey. New Zealand Medical Journal, 120(1251).
Scopus12 Europe PMC3
2007 Kairuz, T., Svirskis, D., Myftiu, J., Behayaa, M., Shahin, D., Thrimawithana, T., . . . Garg, S. (2007). Quality assurance in extemporaneously compounded formulations: A titration method for ursodeoxycholic acid. Hospital Pharmacist, 14(9), 304-306.
2007 Kairuz, T., Chhim, S., Hasan, F., Kumar, K., Lal, A., Patel, R., . . . Garg, S. (2007). Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey. NEW ZEALAND MEDICAL JOURNAL, 120(1251), 48-56.
WoS1
2007 Garg, S., Jambu, L., & Vermani, K. (2007). Development of novel sustained release bioadhesive vaginal tablets of povidone iodine. Drug Development and Industrial Pharmacy, 33(12), 1340-1349.
DOI Scopus17 WoS15 Europe PMC8
2007 Kairuz, T. E., Gargiulo, D., Bunt, C., & Garg, S. (2007). Quality, safety and efficacy in the 'off-label' use of medicines. Current Drug Safety, 2(1), 89-95.
DOI Scopus72 WoS55 Europe PMC34
2007 Kairuz, T., Myftiu, J., Svirskis, D., Hasan, F., Lal, A., Patel, R., . . . Garg, S. (2007). Extemporaneous compounding in New Zealand hospitals. International Journal of Pharmacy Practice, 15(2), 129-131.
DOI Scopus1
2005 Garg, A., Anderson, R. A., Zaneveld, L. J. D., & Garg, S. (2005). Biological activity assessment of a novel contraceptive antimicrobial agent. Journal of Andrology, 26(3), 414-421.
DOI Scopus28 WoS21 Europe PMC16
2005 Garg, S., Vermani, K., Garg, A., Anderson, R. A., Rencher, W. B., & Zaneveld, L. J. D. (2005). Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent. Pharmaceutical Research, 22(4), 584-595.
DOI Scopus97 WoS81 Europe PMC46
2005 Varma, M. V. S., Kaushal, A. M., & Garg, S. (2005). Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. Journal of Controlled Release, 103(2), 499-510.
DOI Scopus111 WoS93 Europe PMC55
2005 Verma, R. K., & Garg, S. (2005). Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. Journal of Pharmaceutical and Biomedical Analysis, 38(4), 633-644.
DOI Scopus151 WoS116 Europe PMC49
2004 Verma, R. K., & Garg, S. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glipizide. European Journal of Pharmaceutics and Biopharmaceutics, 57(3), 513-525.
DOI Scopus105 WoS75 Europe PMC42
2004 Verma, R. K., & Garg, S. (2004). Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. Journal of Pharmaceutical and Biomedical Analysis, 35(3), 449-458.
DOI Scopus88 WoS70 Europe PMC24
2004 Verma, R. K., Arora, S., & Garg, S. (2004). Osmotic pumps in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 21(6), 477-520.
DOI Scopus51 WoS39 Europe PMC19
2004 Varma, M. V. S., Kaushal, A. M., Garg, A., & Garg, S. (2004). Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. American Journal of Drug Delivery, 2(1), 43-57.
DOI Scopus194
2004 Varma, M. V. S., Kaushal, A. M., & Garg, S. (2004). Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of oxybutynin immediate-release and controlled-release formulations. Journal of Pharmaceutical and Biomedical Analysis, 36(3), 669-674.
DOI Scopus20 WoS16 Europe PMC3
2004 Jhamb, S. S., & Garg, S. (2004). Comparative evaluation of different bacterial media for total aerobic bacterial count in deionised water. Indian Journal of Pharmaceutical Sciences, 66(1), 99-101.
2003 Kannan, V., Kandarapu, R., & Garg, S. (2003). Optimization techniques for the design and development of: Novel drug delivery systems, Part II. Pharmaceutical Technology, 27(3), 102-118.
Scopus5
2003 Kannan, V., Kandarapu, R., & Garg, S. (2003). Optimization techniques for the design and development of novel drug delivery systems, part I. Pharmaceutical Technology, 27(2), 74-90.
Scopus13
2003 Tambwekar, K. R., Madhuri, V., Kakaria, R. B., & Garg, S. (2003). An update on pharmacotherapies of smoking cessation. Indian Journal of Pharmaceutical Sciences, 65(5), 450-460.
2003 Tambwekar, K. R., Kandarapu, R., & Garg, S. (2003). An update on microbicides for prevention of sexually transmitted diseases and AIDS. Indian Drugs, 40(2), 75-87.
2003 Garg, S., Kandarapu, R., Vermani, K., Tambwekar, K. R., Garg, A., Waller, D. P., & Zaneveld, L. J. D. (2003). Development pharmaceutics of microbicide formulations. Part I: Preformulation considerations and challenges. AIDS Patient Care and Stds, 17(1), 17-32.
DOI Scopus40 WoS42 Europe PMC24
2003 Garg, S., Tambwekar, K. R., Vermani, K., Kandarapu, R., Garg, A., Waller, D. P., & Zaneveld, L. J. D. (2003). Development pharmaceutics of microbicide formulations. Part II: Formulation, evaluation, and challenges. AIDS Patient Care and Stds, 17(8), 377-399.
DOI Scopus69 WoS49 Europe PMC43
2003 Verma, R. K., Kaushal, A. M., & Garg, S. (2003). Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. International Journal of Pharmaceutics, 263(1-2), 9-24.
DOI Scopus64 WoS51 Europe PMC29
2003 Vasir, J. K., Tambwekar, K., & Garg, S. (2003). Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics, 255(1-2), 13-32.
DOI Scopus481 WoS384 Europe PMC203
2003 Tambwekar, K. R., Kakariya, R. B., & Garg, S. (2003). A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations. Journal of Pharmaceutical and Biomedical Analysis, 32(3), 441-450.
DOI Scopus59 WoS50 Europe PMC26
2002 Arora, P., Sharma, S., & Garg, S. (2002). Permeability issues in nasal drug delivery. Drug Discovery Today, 7(18), 967-975.
DOI Scopus375 WoS298 Europe PMC191
2002 Vermani, K., Garg, S., & Zaneveld, L. J. D. (2002). Assemblies for in vitro measurement of bioadhesive strength and retention characteristics in simulated vaginal environment. Drug Development and Industrial Pharmacy, 28(9), 1133-1146.
DOI Scopus65 WoS49 Europe PMC38
2002 Vermani, K., & Garg, S. (2002). Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology, 80(1), 49-66.
DOI Scopus174 WoS131 Europe PMC77
2002 Garg, S., Vermani, K., Kohli, G., Kandarapu, R., Tambwekar, K., Garg, A., . . . Zaneveld, L. J. D. (2002). Survey of vaginal formulations available on the Indian market: Physicochemical characterization of selected products. International Journal of Pharmaceutical Medicine, 16(3), 141-152.
DOI Scopus12
2002 Gupta, P., Vermani, K., & Garg, S. (2002). Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discovery Today, 7(10), 569-579.
DOI Scopus1624 WoS1449 Europe PMC642
2002 Verma, R. K., & Garg, S. (2002). A validated high performance liquid chromatographic method for analysis of isosorbide mononitrate in bulk material and extended release formulations. Journal of Pharmaceutical and Biomedical Analysis, 30(3), 583-591.
DOI Scopus12 WoS7 Europe PMC3
2002 Verma, R. K., Krishna, D. M., & Garg, S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of Controlled Release, 79(1-3), 7-27.
DOI Scopus315 WoS200 Europe PMC115
2002 Garg, A., Aggarwal, D., Garg, S., & Singla, A. K. (2002). Spreading of semisolid formulations: An update. Pharmaceutical Technology North America, 26(9), 84-105.
Scopus222
2002 Gupta, P., & Garg, S. (2002). Recent advances in semisolid dosage forms for dermatological application. Pharmaceutical Technology, 26(3), 144-162.
Scopus37
2001 Garg, S., Anderson, R. A., Chany, C. J., Waller, D. P., Xia Hui Diao., Vermani, K., & Zaneveld, L. J. D. (2001). Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). Contraception, 64(1), 67-75.
DOI Scopus97 WoS84 Europe PMC62
2001 Garg, S., Tambwekar, K. R., Vermani, K., Garg, A., Kaul, C. L., & Zaneveld, L. J. D. (2001). Compendium of pharmaceutical excipients for vaginal formulations. Pharmaceutical Technology, 25(9 SUPPL.), 14-24.
Scopus66
2001 Kandarapu, R., Grover, V., Chawla, H. P. S., & Garg, S. (2001). Evaluation of the compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing. S T P Pharma Sciences, 11(6), 449-457.
Scopus36 WoS25
2001 Anand, V., Kandarapu, R., & Garg, S. (2001). Ion-exchange resins: Carrying drug delivery forward. Drug Discovery Today, 6(17), 905-914.
DOI Scopus182 WoS142 Europe PMC84
2001 Garg, A., Garg, S., Zaneveld, L. J. D., & Singla, A. K. (2001). Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytotherapy Research, 15(8), 655-669.
DOI Scopus787 WoS662 Europe PMC460
2000 Vermani, K., & Garg, S. (2000). The scope and potential of vaginal drug delivery. Pharmaceutical Science and Technology Today, 3(10), 359-364.
DOI Scopus212 Europe PMC104
2000 Verma, R. K., Mishra, B., & Garg, S. (2000). Osmotically controlled oral drug delivery. Drug Development and Industrial Pharmacy, 26(7), 695-708.
DOI Scopus200 WoS146 Europe PMC85
1999 Amaral, E., Faúndes, A., Zaneveld, L., Waller, D., & Garg, S. (1999). Study of the vaginal tolerance to acidform, an acid-buffering, bioadhesive gel. Contraception, 60(6), 361-366.
DOI Scopus50 WoS52 Europe PMC40
1999 Mukherjee, S., Garg, S., & Talwar, G. P. (1999). Early post implantation contraceptive effects of a purified fraction of neem (Azadirachta indica) seeds, given orally in rats: Possible mechanisms involved. Journal of Ethnopharmacology, 67(3), 287-296.
DOI Scopus31 WoS20 Europe PMC9
1999 Garg, S., Bal, V., Rath, S., & George, A. (1999). Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity. Infection and Immunity, 67(11), 5917-5924.
DOI Scopus14 Europe PMC8
1998 Garg, S., Talwar, G. P., & Upadhyay, S. N. (1998). Immunocontraceptive activity guided fractionation and characterization of active constituents of neem (Azadirachta indica) seed extracts. Journal of Ethnopharmacology, 60(3), 235-246.
DOI Scopus43 WoS28 Europe PMC14
1998 Dhar, R., Zhang, K., Talwar, G. P., Garg, S., & Kumar, N. (1998). Inhibition of the growth and development of asexual and sexual stages of drug-sensitive and resistant strains of the human malaria parasite Plasmodium falciparum by neem (Azadirachta indica) fractions. Journal of Ethnopharmacology, 61(1), 31-39.
DOI Scopus66 WoS55 Europe PMC35
1996 Dhar, R., Dawar, H., Garg, S., Basir, S. F., & Talwar, G. P. (1996). Effect of Volatiles from Neem and Other Natural Products on Gonotrophic Cycle and Oviposition of Anopheles stephensi and An. culicifacies (Diptera: Culicidae). Journal of Medical Entomology, 33(2), 195-201.
DOI Scopus74 WoS61 Europe PMC28
1995 Mittal, A., Kapur, S., Garg, S., Pharma, M., Upadhyay, S. N., Suri, S., . . . Talwar, G. P. (1995). Clinical trial with praneem polyherbal cream in patients with abnormal vaginal discharge due to microbial infections. Australian and New Zealand Journal of Obstetrics and Gynaecology, 35(2), 190-191.
DOI Scopus13 WoS11 Europe PMC8
1994 Garg, S. (1994). Antifertility activity of Neem (Azadirachta indica) extracts. Indian Drugs, 31(9), 401-404.
Scopus1
1994 Garg, S., Talwar, G. P., & Upadhyay, S. N. (1994). Comparison of extraction procedures on the immunocontraceptive activity of neem seed extracts. Journal of Ethnopharmacology, 44(2), 87-92.
DOI Scopus12 WoS8 Europe PMC4
1994 Gupta, A., Garg, S., & Khar, R. K. (1994). Interpolymer complexation and its effect on bioadhesive strength 6 dissolution characteristics of buccal drug delivery systems. Drug Development and Industrial Pharmacy, 20(3), 315-325.
DOI Scopus41 WoS28
1994 Garg, S., Doncel, G., Chabra, S., Upadhyay, S. N., & Talwar, G. P. (1994). Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride. Contraception, 50(2), 185-190.
DOI Scopus45 WoS34 Europe PMC22
1993 Talwar, G. P., Singh, O., Pal, R., Chatterjee, N., Upadhyay, S. N., Kaushic, C., . . . Gupta, A. (1993). A birth control vaccine is on the horizon for family planning. Annals of Medicine, 25(2), 207-212.
DOI Scopus11 WoS8 Europe PMC6
1993 Garg, S., Taluja, V., Upadhyay, S., & Talwar, G. (1993). Studies on the contraceptive efficacy of Praneem polyherbal cream. Contraception, 48(6), 591-596.
DOI Scopus38 WoS34 Europe PMC16
1993 Gupta, A., Garg, S., & Khar, R. K. (1993). Measurement of bioadhesive strength of mucoadhesive buccal tablets: Design of an in-vitro assembly. Indian Drugs, 30(4), 152-155.
Scopus166
1992 Gupta, A., Garg, S., & Khar, R. K. (1992). Mucoadhesive buccal drug delivery systems: A review. Indian Drugs, 29(13), 586-593.
Scopus31
1992 Upadhyay, S. N., Dhawan, S., Garg, S., & Talwar, G. P. (1992). Immunomodulatory effects of neem (Azadirachta indica) oil. International Journal of Immunopharmacology, 14(7), 1187-1193.
DOI Scopus105 WoS79 Europe PMC48

Year Citation
2022 Garg, S. (2022). Foreword - Computer Aided Pharmaceutics and Drug Delivery: an Application Guide for Students and Researchers of Pharmaceutical Sciences. In V. Saharan (Ed.), Source details - Title: Computer Aided Pharmaceutics and Drug Delivery: an Application Guide for Students and Researchers of Pharmaceutical Sciences (pp. vii-viii). Singapore: Springer.
2021 Day, C. M., Sweetman, M. J., & Garg, S. (2021). Mesoporous silica nanoparticles for drug combination delivery in cancer therapy: Background, current insights, and future perspectives. In Nanocarriers for the Delivery of Combination Drugs (pp. 119-162). Netherlands: Elsevier.
DOI Scopus4
2021 Shrivastava, N., Parikh, A., Chaudhuri, A., Ali, J., Baboota, S., & Garg, S. (2021). Lipid-based combinational drug delivery systems: maximizing the performance of cocktail therapy. In S. Baboota, & J. Ali (Eds.), Source details - Title: Nanocarriers for the Delivery of Combination Drugs (pp. 259-305). Netherlands: Elsevier.
DOI Scopus2
2021 Shrivastava, N., Parikh, A., Chaudhuri, A., Ali, J., Baboota, S., & Garg, S. (2021). Lipid-based combinational drug delivery systems. In Nanocarriers for the Delivery of Combination Drugs (pp. 259-305). Elsevier.
DOI
2021 Day, C. M., Sweetman, M. J., & Garg, S. (2021). Mesoporous silica nanoparticles for drug combination delivery in cancer therapy. In Nanocarriers for the Delivery of Combination Drugs (pp. 119-162). Elsevier.
DOI
2018 Day, C. M., Barclay, T. G., Song, Y., & Garg, S. (2018). Swelling-controlled drug delivery systems. In A. Singh, & M. M. Amiji (Eds.), Source details - Title: Stimuli-responsive Drug Delivery Systems (pp. 232-264). UK: Royal Society of Chemistry.
DOI
2018 Day, C. M., Parikh, A., Song, Y., & Garg, S. (2018). Nanotechnology and nature's miracle compound: curcumin. In B. Singh, M. Hakkarainen, & K. K. Singh (Eds.), Source details - Title: NanoNutraceuticals (pp. 213-253). US: CRC Press.
2013 Sharma, M., Svirskis, D., & Garg, S. (2013). Advances in drug-delivery systems based on intrinsically conducting polymers. In C. Alverez-Lorenzo, & A. Concheiro (Eds.), Source details - Title: RSC Smart Materials for Drug Delivery: volume 1 (Vol. 1, pp. 283-303). US: RSC Publishing.
DOI Scopus8
2010 Sharma, P., Ganta, S., & Garg, S. (2010). Scale-Up and Postapproval Changes (SUPAC) Regulations. In Source details - Title: Pharmaceutical Manufacturing: Regulations and Quality (pp. 67-95). US: John Wiley & Sons Ltd.
DOI Scopus1
2008 Ganta, S., Sharma, P., & Garg, S. (2008). Permeability assessment. In Source details - Title: Preclinical Development Handbook: ADME and Biopharmaceutical Properties (Pharmaceutical Development Series) (pp. 227-248). USA: John Wiley & Sons Ltd.
DOI Scopus1

Year Citation
2017 Zhou, X., Parikh, A., & Garg, S. (2017). WO2017157350, Edaravone dosage form.
2016 Page, S., & Garg, S. (2016). US20160058717, Methods for treating bacterial infections.
2014 Page, S., Garg, S., Keenan, M., McCluskey, A., & Stevens, A. (2014). WO2014176636, Compounds and methods of treating infections.
2014 Page, S., & Garg, S. (2014). WO2014121343, Methods of treating microbial infections, including Mastitis.
2013 Garg, S., Vermani, K., Kohli, G., Raghupathi, K., Tambwekar, K., & Kaul, C. L. (2013). IN257997, A process for the preparation of a rapidly disintegrating bioadhesive pharmaceutical composition.
2003 Garg, S., Vermani, K., Arora, P., Kohli, G., Raghupathi, K., & Tambwekar, K. (2003). IN225919, A pharmaceutical composition of high molecular weight polymeric drugs.
2003 Garg, S., Verma, R. K., & Kaul, C. L. (2003). WO2003063825, Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient.
2001 Garg, S., Zaneveld, L. J. D., Anderson Jr., R. A., & Waller, D. P. (2001). WO2001066084, Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa.

Year Citation
2025 Uddin, A. H. M. M., Taechamaeteekul, P., Petrovski, K., Tummaruk, P., Song, Y., Garg, S., & Kirkwood, R. (2025). Development of Timed Release Vaginal Mucosal Cloprostenol for Farrowing Management in Sows.
DOI
2023 Abdella, S., Kim, S., Afinjuomo, F., Song, Y., Upton, R., & Garg, S. (2023). Harnessing the Synergistic Potential of 3D Printed Buccal Films and Nanostructured Lipid Carriers (NLCs) For Personalised Cannabidiol Delivery.
DOI

  • Biopharmaceuticals research services, Neoculi Pty Ltd, 19/03/2025 - 18/03/2030

  • A novel drug class for the effective treatment of Giardia infections, ARC - Linkage Project, 13/12/2023 - 12/12/2026

  • Neoculi: A novel drug class for the effective treatment of Giardia infections, Neoculi Pty Ltd, 13/12/2023 - 12/12/2026

  • Development of a Meloxicam-Loaded Transdermal Patch and Its In-Vitro and In-VivoEvaluation, SunPork Consolidated Pty Ltd, 04/11/2025 - 30/10/2026

  • Future-proofing Against Resistant Bacterial Priority Pathogens: Innovative Formulations to Treat Infections and Save Lives, Australia's Economic Accelerator Ignite Grant, 30/06/2025 - 29/06/2026

  • Development of New Anthelmintic Combination Formulations, Elanco Australasia Pty Ltd, 19/12/2024 - 30/04/2026

  • A novel dual therapy approach to treatment of multidrug-resistant Gram-negative infections, NHMRC - Ideas Grants, 01/04/2023 - 31/03/2026

  • Developing Nanoparticle Mediated Gene Transfer for Childhood Dementia, Medical Research Future Fund, 01/07/2023 - 31/01/2026

  • Reconstitution Performance and Quality Attribute Comparison of Piperacillin/Tazobactam Injectable Products, AFT Pharmaceuticals Pty Ltd, 17/05/2025 - 30/06/2025

  • Development of the Second-Generation Amphora Formulations, EVOFEM Biosciences, 03/02/2020 - 30/06/2022

  • Stability studies of Omeprazole, Luoda Pharma Pty Ltd, 20/07/2020 - 20/04/2021

  • FIA056 - Ind Ptnr - Development of a novel and innovative melatonin film for treatment of insomnia, Green Dispensary Pty Ltd, 01/02/2020 - 30/11/2020

  • FIA038 Ind Ptnr - Development of a Novel Taste Masked Oral Antimicrobial Preparation for Aquaculture, Clean Seas Seafood Limited, 07/02/2019 - 31/05/2020

  • Stability Evaluation of Extemporaneously Compounded Oral Flecainide, Pharmac, 18/07/2019 - 06/12/2019

  • Drug targeting to immune cells using modified inulin particles, ARC - Linkage Project, 05/05/2015 - 30/06/2019

  • An Extraction Method Development for Tilmicosin in Tilmovet, SunPork Solutions, 16/04/2018 - 31/05/2018

  • Pharmaceutical product development of a range of new compounds and existing drugs for human and veterinary applications, Luoda Pharma Pty Ltd, 06/04/2015 - 06/04/2018

Date Role Research Topic Program Degree Type Student Load Student Name
2022 External Supervisor Non-injection administration of GnRH for control of ovarian function Doctor of Philosophy Doctorate Full Time Mr A H M Musleh Uddin

Date Role Research Topic Program Degree Type Student Load Student Name
2019 - 2022 External Supervisor Management of sows and their piglets around the periparturient period: observing the effects on survival and performance of the litter Doctor of Philosophy Doctorate Full Time Miss Sophia Alexandra Ward

Connect With Me

External Profiles

Other Links